Supporting Innovation and Entrepreneurship for more than 60 years

Welcome to Safeguard Scientifics' Blog, where we share Perspective, Strategy and Insight.

Archive: James A. Datin

Corporate

Safeguard Scientifics Announces Resignation of James A. Datin

Today, Safeguard announced that Jim Datin has resigned effective June 30, 2013. “Jim Datin is a talented executive and consummate professional for whom we wish only the best in the next chapter of his career,” said Stephen T. Zarrilli, Safeguard’s President and Chief Executive Officer.  “He helped revitalize and refocus the Company and leaves the Company in excellent financial and strategic condition.  As a…

Read more

Life Sciences

6 Trends That Will Shape Healthcare in 2013

With President Obama winning another four years in the oval office, the palpable uncertainty created by the Supreme Court ruling on the Affordable Care Act has been supplanted by a more stable outlook for the healthcare industry overall as 36 million more Americans join the health insurance ranks as we enter 2013. So, with that issue resolved, what can healthcare…

Read more

Life Sciences

Anatomy of a Deal: Avid Radiopharmaceuticals

This morning, I presented at the 2012 Annual RBC Biotech Conference, which focused on the “Biotech Success Stories of the [Philadelphia] Region”. I was asked to speak about Safeguard’s success with our life sciences partner company, Avid Radiopharmaceuticals, which was acquired in December 2012 by Eli Lilly. The following presentation, entitled “The Success of Avid Pharmaceuticals from an Investor’s Point…

Read more

Investor Day

Safeguard Scientifics Investor Day 2012 Replay and Resources

Unable to join us yesterday for Safeguard Scientifics Investor Day 2012? Here is a list of available resources that will provide with a thorough recap of our event: WEBCAST — The webcast from yesterday’s event is available at www.safeguard.com/InvestorDay2012 and will be available until November 9, 2012 at 9:00am ET. AUDIO REPLAY — You can dial into the event replay at 877-344-7529 or (International) +412-317-0088.…

Read more